MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.02983-2021

Медицинская библиотека · The European respiratory journal · 2022

Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma.

Kroes Johannes A, Zielhuis Sybrand W J, De Jong Kim, Hashimoto Simone, Sont Jacob K, Zielhuis Sander W, Van Roon Eric N, Bel Elisabeth H, Ten Brinke Anneke, RAPSODI Team

Наблюдательное исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Anti-interleukin (IL)-5/IL-5 receptor α (IL-5Ra) therapy has been shown to reduce maintenance oral corticosteroid (OCS) dose in severe eosinophilic asthma. However, the effect on cumulative OCS exposure is currently unknown. Neither is it known how prior OCS exposure affects response to anti-IL-5/5Ra treatment. We aimed primarily to compare the cumulative OCS exposure over a 2-year period before and after anti-IL-5/5Ra initiation, and secondarily to investigate whether duration and cumulative OCS exposure prior to anti-IL-5/5Ra influence the ability to discontinue OCS within 2 years of anti-IL-5/5Ra therapy.

METHODS

This real-world nationwide observational registry-based study evaluated all dispensed OCS from 389 adults with severe eosinophilic asthma included in the Dutch Severe Asthma Registry (RAPSODI) 2 years before and 2 years after initiating anti-IL-5/5Ra. The Wilcoxon signed-rank test and multivariable regression analyses were used.

RESULTS

Median (interquartile range) cumulative OCS exposure in the 2 years before and after anti-IL-5/5Ra initiation decreased from 2.715 (1.150-5.539) to 1.050 (0.300-3.640) g (p<0.001). 52% of patients were able to discontinue OCS within 2 years after anti-IL-5/5Ra therapy, which was independently predicted by lower and shorter prior OCS exposure.

CONCLUSIONS

This real-world study showed that anti-IL-5/5Ra therapy leads to a significant reduction in cumulative OCS exposure over a 2-year period. Patients with lower and shorter OCS exposure were more likely to completely eliminate OCS. Since cumulative exposure increased progressively prior to anti-IL-5/5Ra initiation, our data suggest that early intervention leads to a better long-term prognosis in patients with severe eosinophilic asthma.

Для цитирования: Kroes Johannes A, Zielhuis Sybrand W J, De Jong Kim, Hashimoto Simone, Sont Jacob K, Zielhuis Sander W, Van Roon Eric N, Bel Elisabeth H, Ten Brinke Anneke, RAPSODI Team. Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma.. The European respiratory journal. 2022. DOI: 10.1183/13993003.02983-2021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.